The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …
Big Pharma – Hitting a Wall?
From today's Wall Street Journal (subscription may be required) Over the next few years, the pharmaceutical business will hit a wall. Some of the top-selling drugs in industry history will become …